| COLUMNS: BILLING & CODING |
|
|
|
Tips for Coding Correctly in 2007
POLICY & MANAGEMENT | ISSUE: FEBRUARY, 2007
New coding changes, the Medically Unlikely Edits project and the safe use of modifiers were among the topics discussed by Douglas Merrill, MD, at the 2006 fall pain meeting of the American Society of Regional Anesthesia and Pain Medicine. |
Make the Most of the New CPT Changes In Billing for Consultation Services
POLICY & MANAGEMENT | ISSUE: JUNE, 2006
Pain medicine specialists are highly trained providers to whom other physicians frequently refer patients for advanced services or consultations. The need for a physician to request advice or expert opinion from a colleague, in the form of a professional consultation, is almost as old as medicine itself. |
New CMS Codes For Rechargeable Neurostimulators
POLICY & MANAGEMENT | ISSUE: FEBRUARY, 2006
The Centers for Medicare and Medicaid Services (CMS) introduced several new reimbursement codes for rechargeable neurostimulators that are effective for services performed in an ambulatory surgery center (ASC) setting on or after January 1, 2006. In addition, CMS approved New Technology Add-On payments for rechargeable neurostimulators used in the hospital inpatient setting that became effective October 1, 2005. |
Facet Joint Block Coding Confuses Medicare Contractors, Payers
POLICY & MANAGEMENT | ISSUE: AUGUST, 2005
Y2K brought new codes and revisions of Medicare fee schedules to the specialty of pain management. |
Consultant Offers Advice To Reduce No-Show Appointments
Patients Who Miss Appointments Can Cost A Medical Practice Money and Staff Resources
POLICY & MANAGEMENT | ISSUE: AUGUST, 2005
No-shows--missed appointments--are one of the biggest problems in medical practice. No-shows mean lost revenue for the practice and wasted time for physicians, technicians, nurses and other staff. The lost revenue will never be recovered, and additional practice resources will be used to contact and reschedule the patient who did not make his or her appointment. |
Expert Advises on Reimbursement For Botulinum Toxin To Treat Pain
POLICY & MANAGEMENT | ISSUE: FEBRUARY, 2005
The U.S. Food and Drug Administration approved botulinum toxin for the treatment of blepharospasm in the 1990s. At that time, the only form of botulinum toxin available was type A (Botox, Allergan). In 2000, the FDA approved the use of both Botox and botulinum toxin type B (Myobloc, Solstice Neurosciences) for the treatment of cervical dystonia.
|
Coding Expert Advises on Intradiskal Electrothermal Therapy Reimbursement
POLICY & MANAGEMENT | ISSUE: OCTOBER, 2004
Since its inception in February 2003, Pain Medicine News has received an overwhelming number of re"quests from readers for information and tips on Current Procedural Terminology (CPT) coding for pain procedures. As a result of this feedback, we are pleased to announce the first of an ongoing series written by coding expert Joanne Mehmert, CPC. |